CLICK ABOVE FOR AUDIO
SELECTED TO JOIN ILLUMINA’S EIGHTH ACCELERATOR CLASS
Illumina Accelerator welcomes Cognitive Genetics to its 8th investment cycle. Illumina, the genomics-based company creation engine, established it’s Accelerator program to help building early-stage genomics companies. Illumina helps startups validate and create next-generation sequencing applications and bring those products to market. During the six-month cycle, Illumina Accelerator offers the selected companies access to capital, genomics and sequencing expertise, business coaching, as well as lab and office space at Illumina’s Bay Area campus.
DYSLEXIA A GENETIC PROBLEM
Dyslexia – despite conventional wisdom – is actually a genetic problem that is addressable. By basing screening on genetics, we can identify children at high risk well before they struggle with reading curriculum, and even before they enter school.
Multiple independent twin and family studies show that the heritability of dyslexia is between 50% and 80% - that is to say that 50% to 80% of the variance in reading performance can be explained by genetic factors.
SCREENING FOR GLOBAL MARKET
~8 to ~15% of the global population carry the gene profile for the 3 main learning disabilities for which CogGen screens.
The current standard screening test for LDs is prohibitively expensive, lacks scale, and involves a long process with school teachers, specialists, pediatricians, psychiatrists, family, and the young child.
Most children suffering from LDs are not diagnosed until later in their school years if they are fortunate to be diagnosed at all.
The CogGen screener is scalable, significantly less costly, and available to be given years before a child is of reading age.